CTOs on the Move

careMESH

www.caremesh.com

 
careMESH is a first-of-its-kind healthcare communications platform bringing together a national provider directory, admit/discharge notifications, secure communications, and transition of care workflows into a single service. careMESH connects the care continuum by allowing any provider working with any electronic health record to communicate and collaborate with any other, instantly. careMESH`s cloud-based services efficiently allow hospitals and health systems, health information exchanges, public health agencies, and physician groups to communicate about patients, maintain complete control over when and where information is shared, and rapidly reduce reliance on outdated tools such as fax and phone calls.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.caremesh.com
  • 12110 Sunset Hills Road Suite 600
    Reston, VA USA 20190
  • Phone: 703.691.6128

Executives

Name Title Contact Details
Gustavo Bonany
Chief Technology Officer Profile

Similar Companies

ChromaDex

ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex`s patent portfolio. ChromaDex delivers Niagen® as the sole active ingredient in its consumer product, Tru Niagen® — available at www.truniagen.com and through partnerships with global retailers and distributors.

Burgess Health Center

Burgess Health Center is committed to improve the quality of life for the people and communities we serve by providing excellent healthcare and exceptional patient experiences.

scPharmaceuticals

scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.

Myocor

Myocor is a Osseo, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Laerdal Medical

Laerdal Medical Corporation maintains a national sales field team to assist customers with product information and demonstrations. Please use our contact form to request the name of your Laerdal Sales Representative.